Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SECNIDAZOLE vs SELUMETINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SECNIDAZOLE vs SELUMETINIB: Safety Overview

Metric SECNIDAZOLE SELUMETINIB
Total FAERS Reports 245 1,172
Deaths Reported 1 81
Death Rate 0.4% 6.9%
Hospitalizations 10 211
Average Patient Age 40.4 yrs 25.6 yrs
% Female Patients 95.6% 51.6%
FDA Approval Date Sep 15, 2017 Apr 10, 2020
Manufacturer Evofem Inc. AstraZeneca Pharmaceuticals LP
Route ORAL ORAL
Marketing Status Prescription Prescription